Sentences with phrase «of breast or ovarian cancer»

Where you have been diagnosed with later stages of both breast or ovarian cancer most individuals will need to pursue an «alternative» life insurance product such as a guaranteed issue life insurance policy if they wish to purchase a life insurance policy on themselves.

If women are considered high - risk because of personal or family history of breast or ovarian cancer, the U.S. Preventive Services Task Force recommends BRCA testing.

Women are generally in this group if they have multiple cases of breast or ovarian cancer in the family, a positive result on the BRCA breast cancer gene - mutation test, a personal history of the disease, or a biopsy showing atypia or lobular carcinoma in situ.

The most important risk factor for ovarian cancer is a strong family history of breast or ovarian cancer.

Researchers conducted an analysis that included nearly 10,000 women with the BRCA1 or BRCA2 genetic mutations to estimate the age - specific risk of breast or ovarian cancer for women with these mutations, according to a study published by JAMA.

Where mutations occur in two important cancer genes can affect a woman's risk of breast or ovarian cancer, a study of thousands of women shows.

Many doctors who no longer advise mammograms for most women younger than 50 continue to suggest them for those with a family history of breast or ovarian cancer.

For that reason, the American Cancer Society recommends annual MRI screenings only in women with a strong family history of breast or ovarian cancer.

Breastfeeding has been shown to lower your risk of breast or ovarian cancer, and maybe even osteoporosis.

Not exact matches

Kale is a member of the brassica family or cruciferous vegetables (along with broccoli, cabbage, cauliflower, Brussels sprouts) which have a protective effect in a variety of cancers, including breast, colon, prostate, bladder and ovarian cancers.

Lori Getz, MA, shares advice from her experience on what the odds of getting breast and / or ovarian cancer with a BRCA mutation

As well as bonding with the baby when sharing the breastfeeding, lesbian parents report enjoying the effects of the relaxation hormones released when lactating (resulting in lower stress levels in the parent and baby), the flexibility of having two nursing parents when one needs to absent herself occasionally or when returning to work, and the health benefits of breastfeeding such as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9).

Women for whom genetic testing is recommended are: women who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast cancer.

Breastfeeding can also reduce the chances for some women of getting diseases such as breast or ovarian cancer later in life.

It can also help lower your chances of developing breast or ovarian cancers, plus it helps you bond with your baby, saves you money and can use up to 500 calories a day.

They can also reduce your chance of developing type 2 diabetes, postpartum depression and breast or ovarian cancer.

Reams of research have linked breastfeeding to scores of benefits for both mom and baby: breast - fed babies aren't as likely to fall prey to obesity, ear infections or diabetes; breast - feeding moms benefit from a decreased risk of breast and ovarian cancer.

Moms who breastfeed for a total of 12 months through their life or participate in extended breastfeeding for their baby's first year of life or longer may have a decreased risk of developing breast or ovarian cancer, heart disease, diabetes, rheumatoid arthritis, and other diseases.

A family or personal history of ovarian cancer, breast cancer or colorectal cancer increase a woman's risk as well.

It has a positive impact on childhood obesity, infections and allergies, is linked to a lower likelihood of mothers getting ovarian or breast cancers later in life and to a more positive maternal - child relationship.

Of Joseph's eight aunts, five had died of either breast or ovarian canceOf Joseph's eight aunts, five had died of either breast or ovarian canceof either breast or ovarian cancer.

When examining reproductive cancers, the authors noted that while patients with infertility were 44 percent more likely to die of breast cancer, infertility was not associated with an increased risk of ovarian cancer or death from ovarian or endometrial cancers.

About a quarter of patients had mutations in the DNA repair genes including BRCA1 or BRCA2 genes, which are known to increase the risk of breast and ovarian cancer.

Women with a family history of two or more immediate family members (mother, sister, daughter) with breast or ovarian cancer or with a positive genetic test for mutations in the BRCA1 or BRCA2 genes may be advised to consider having both breasts removed, because they are at high risk of a new cancer developing in the other breast.

Of the 511 women who died during this study, 333 died of breast cancer, 68 from ovarian, fallopian tube, or peritoneal cancers, and the remainder from other causeOf the 511 women who died during this study, 333 died of breast cancer, 68 from ovarian, fallopian tube, or peritoneal cancers, and the remainder from other causeof breast cancer, 68 from ovarian, fallopian tube, or peritoneal cancers, and the remainder from other causes.

P: We found discodermolide [a drug from Discodermia, a sponge found in the Caribbean, the Bahamas, and the Gulf of Mexico], and it's gone through phase I clinical trials for treatment of solid tumors such as ovarian, pancreatic, breast, colon, or lung cancers.

Antonis C. Antoniou, Ph.D., of the University of Cambridge, England, and colleagues included 6,036 BRCA1 and 3,820 BRCA2 female carriers (5,046 unaffected and 4,810 with breast or ovarian cancer or both at study entry) in the analysis.

For example, eight children with leukemia or other cancers had mutations in genes that dramatically raise risk of breast and ovarian cancer in adults — the BRCA genes and PALB2.

If a woman with a strong family history of breast and ovarian cancers tests negative for the BRCA1 / 2 genes, that does not mean her relatives are not at risk, says Daly — her siblings could still carry the gene, or there could be additional genes present that predispose them to cancer that clinicians don't yet know how to test for.

The commercial testing occurred because the patients had a severe family history of breast cancer, defined as a family with three or more relatives affected by breast or ovarian cancer.

This spring, a group of geneticists urged labs to actively look for incidental findings, such as certain genes predisposing to breast and ovarian cancer, and return those results whether people want them or not.

All nine patients also had lost portions of chromosomes containing one or both BRCA1 and BRCA2 genes, which have long been linked to hereditary as well as sporadic breast and ovarian cancers.

It has had particularly strong results in phase III trials in patients who inherited mutations to the BRCA genes, many of whom had breast or ovarian cancer.

«A large majority of cancers present symptomatically, but symptoms may be subtle especially in the early stages in certain cancer types such as gastric, pancreatic or ovarian cancers, as opposed to say a more obvious palpable mass such as in breast cancer.»

To identify segments across the intronic and exonic regions of the BRCA1 or BRCA2 genes associated with different breast vs ovarian cancer risks, we created bins of mutations by base pair location (Figure 1).

SHARE helps people through breast or ovarian cancer, from diagnosis through treatment and post-treatment, offering the unique support of survivors who've been there.

Some of the factors associated with an increased likelihood of a BRCA1 or BRCA2 mutation include breast cancer diagnosis before age 50; both breast and ovarian cancers; multiple breast cancers; cases of male breast cancer and Ashkenazi Jewish ethnicity.

This Fund will help underinsured Georgians with a family history of Hereditary Breast and Ovarian Cancer (HBOC) who would otherwise not be able to afford genetic testing or have no insurance coverage for it receive needed genetic testing.

These interests grew from studies of paraneoplastic neurologic disorders (PNDs), a group of diseases thought to arise when tumors — typically breast, ovarian, or lung cancers — start making proteins normally only made by the brain.

GENIC has completed (or has ongoing) a series of studies to examine the interaction between environmental risk factors and susceptibility genes for non-Hodgkin lymphoma, melanoma, and multiple myeloma, as well as breast, ovarian, and prostate cancers.

The DNA repair deficiency, called homologous recombination deficiency, or HRD, has previously been studied in only a few cancers, but as researchers at Georgetown Lombardi Comprehensive Cancer Center report, HRD can be found in all of the cancer types the researchers studied, including prostate, breast, pancreatic, and endometrial cancers as well as two of the more deadly types: ovarian cancer and glioma, a type of brain cCancer Center report, HRD can be found in all of the cancer types the researchers studied, including prostate, breast, pancreatic, and endometrial cancers as well as two of the more deadly types: ovarian cancer and glioma, a type of brain ccancer types the researchers studied, including prostate, breast, pancreatic, and endometrial cancers as well as two of the more deadly types: ovarian cancer and glioma, a type of brain ccancer and glioma, a type of brain cancercancer.

Rogan, Canada Research Chair in Genome Bioinformatics, says that 16 to 20 per cent of women in southwestern Ontario, who have their BRCA genes tested for breast and / or ovarian cancer risk, carry disease - causing gene variants that are well - understood by clinicians and genetic counselors.

Paclitaxel (Taxol ®) is a widely - used anticancer agent for treatment of ovarian, breast, lung, head, and neck cancer with two serious side effects: myelosuppression and peripheral sensory neurotoxicity which limits its use in high / cumulative doses or in combination with other anticancer agents.

You or a family member are of Ashkenazi Jewish ancestry (Eastern or Central European descent) and have either breast or ovarian cancer.

Overholser and colleagues discuss the role of endocrine therapy to reduce risk for breast cancer, and cite interesting data from patients who developed premature ovarian failure due to ovarian irradiation or alkylating chemotherapeutic agents, which demonstrates that these patients were at decreased risk for developing subsequent breast cancer.

Testing for mutations in the BRCA1 or BRCA2 genes can help women learn if they are more likely to develop breast or ovarian cancer, which can lead them to get screened more regularly and take advantage of effective treatments.

• Cancer prevention: A 2009 review of 51 green tea studies found that sipping three to five cups a day may lower the risks of ovarian, colorectal, lung, and prostate cancers, but not breast or other cancers, says lead author Katja Boehm, research fellow at the Center of Integrative Medicine at the University of Witten / Herdecke in Germany.

I've learned from lactation consultants that things like immunity support, gut health, and retina and cognitive development for the baby and faster recovery, increased emotional health, and even lower risks of ovarian or breast cancer for the mom.

But there are exceptions to the no - screening rule: If you have a strong family or personal history of breast cancer or ovarian cancer, talk to your doctor about getting tested.

For example, if one of your relatives had both breast and ovarian cancer — or breast cancer that was diagnosed before she turned 50 — you would be a candidate for the test.